Internal Medicine, Hematology & Oncology · White Plains, NY
NPI
1578559910
Since 2005
Specialty
Internal Medicine, Hematology & Oncology
Code 207RH0003X
Group practices
1
Medicare group memberships
Hospitals
1
Hospital affiliations
2 Longview Ave, Ste 201
White Plains, NY, 10601
Phone (914) 684-2779
Groups this clinician bills Medicare through
Medicare paid, 2024
$27K
299 services
Medicare patients, 2024
116
Average age 74
Drug cost, 2024
$1.3M
820 prescriptions
Company payments, 2025
$58.48
From 3 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Della F Makower was code 99214 (office e&m - established), 138 times for 62 patients. In total Della F Makower billed 299 services in 11 codes, and Medicare paid $27K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2008-03-26.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Office | 138 | 62 | $84.89 | $12K |
| 99232 Hospital E&M - Subsequent | Facility | 57 | 23 | $72.71 | $4,144 |
| 99233 Hospital E&M - Subsequent | Facility | 30 | 13 | $104.04 | $3,121 |
| 99213 Office E&M - Established | Office | 17 | 16 | $62.90 | $1,069 |
| 99205 Office E&M - New | Office | 16 | 16 | $212.16 | $3,394 |
By year: 2022 $39K for 453 services; 2023 $31K for 363 services; 2024 $27K for 299 services.
Medicare prescription drug claims, 2024
In 2024, the drug Della F Makower prescribed most often to Medicare patients was Anastrozole, with 385 prescriptions and refills. In total Della F Makower wrote 820 Medicare prescriptions that cost $1.3M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Anastrozole Generic | 385 | 648 | 86 | $4,403 |
| Exemestane Generic | 85 | 174 | 23 | $13K |
| Tamoxifen Citrate Generic | 72 | 90 | Under 11 | $878 |
| Letrozole Generic | 52 | 84 | 12 | $611 |
| Lidocaine-Prilocaine Lidocaine/Prilocaine | 31 | 31 | 16 | $259 |
| Ibrance Palbociclib | 28 | 28 | Under 11 | $428K |
| Ondansetron Hcl Generic | 26 | 28 | 14 | $53.99 |
| Orserdu Elacestrant Hcl | 22 | 22 | Under 11 | $508K |
| Verzenio Abemaciclib | 15 | 15 | Under 11 | $221K |
| Famotidine Generic | 13 | 13 | Under 11 | $36.66 |
Brand drugs: 94 claims; generic drugs: 726 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Della F Makower $58.48 ($58.48 in general payments such as food, travel and fees) from 3 companies. The largest payer was Stemline Therapeutics Inc. with $35.62.
| Company | Payments | Amount |
|---|---|---|
| Stemline Therapeutics Inc. | 2 | $35.62 |
| Merck Sharp & Dohme LLC MRK | 1 | $22.86 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.